最新ニュース CalciMedica (NASDAQ:CALC) 株価情報

CalciMedica

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

CalciMedica Inc

Calcitech Ltd

Calcol Inc

Earnings

ABNB

AENT

AGIO

ALNY

AMAT

APDN

ATUS

AVNT

BENF

BFAM

BLIN

BPMC

BRKR

BTOC

CBRE

CEVA

CLBT

CNVS

COHU

COIN

CROX

CYBR

DDOG

DKNG

DNOW

DXCM

EEFT

EGAN

ELME

ELVA

FBRT

FROG

GDDY

GEHC

GPMT

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HIMX

HOUS

HTGC

IMPP

INFA

IRDM

IRMD

ISSC

KELYA

KELYB

KNSL

LECO

LGCY

LPTH

NTWK

NVMI

Earnings Scheduled For February 13, 2025

Honda Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) reported quarterly earnings of $1.31 per share. This is a 23.58 percent increase over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $36.317 billion which beat the analyst consensus estimate of $34.098 billion by 6.51 percent. This is a 0.46 percent decrease over sales of $36.486 billion the same period last year.

Earnings Beats

News

Honda Motor Co Q3 2025 GAAP EPS $1.31 Up From $1.06 YoY, Sales $36.317B Beat $34.098B Estimate

FFIE

Reported Earlier, Faraday Future FF 91 2.0 Achieves 76% Residual Value As First Used Model Sells For $235,000 On Bring A Trailer

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk on Thursday said that he is unaware of a <a href="https://www.benzinga.com/markets/equities/25/02/43683937/teslas-400-million-armored-cybertruck-deal-under-fire-as-short-seller-jim-chanos-questions-elon-musks-doge-role-in-cutting-wasteful-government-spending">potential contract for $400 million</a> to provide armored vehicles to the government.
What Happened: &#8220;I'm pretty sure Tesla isn't getting $400M. No one mentioned it to me, at least,&#8221; Musk said in a post reply on social media platform X, formerly Twitter.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I'm pretty sure Tesla isn't getting $400M. No one mentioned it to me, at least.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1889925100918677690?ref_src=twsrc%5Etfw">February 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The U.S. State Department&#8217;s procurement forecast for 2025 had previously included a potential $400 million armored electric vehicle purchase from Tesla starting in the fourth quarter of 2025 and spanning five years. 
However, the department has now dropped the name of the Musk-lead EV company from the document, instead choosing not to name a manufacturer, after it raised <a href="https://www.benzinga.com/markets/equities/25/02/43683937/teslas-400-million-armored-cybertruck-deal-under-fire-as-short-seller-jim-chanos-questions-elon-musks-doge-role-in-cutting-wasteful-government-spending">conflict of interest concerns</a> provided Musk is now leading the Department of Government Efficiency in the Trump presidency. 
The document, however, continues to list planned armored BMW X5/X7 purchases for $40 million as well as other armored sedan and EV purchases from unnamed manufacturers. All these contracts, however, are only in the planning stage.
Why It Matters: Tesla makes no military vehicles. However, the company touts the latest addition to its lineup- the Cybertruck- to be bulletproof. Musk has previously even termed the vehicle as the &#8220;finest in apocalypse defense technology.&#8221;
The premium variant of the Cybertruck is priced at around $100,000, and a $400 million contract would have got the government nearly 4000 Cybertrucks and provided a big boost to Musk&#8217;s EV company after it reported a <a href="https://www.benzinga.com/tech/25/01/43327268/tesla-expects-50-surge-in-energy-storage-deployments-for-2025-after-segment-revenue-doubles-in-q4">drop in revenue from its automotive segment last year</a>.
In 2024, the company reported a 6% drop in automotive revenue to $77.07 billion following a drop in annual deliveries and <a href="https://www.benzinga.com/news/24/10/41443856/tesla-offers-discounts-of-up-to-4k-on-select-model-3-y-vehicles-as-it-looks-to-avert-1st-ever-declin">discounting aimed at increasing demand</a>. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a> 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/02/43683612/tesla-fights-supercharger-vandalism-and-theft-with-dye-bombs-cable-engravings">Tesla Fights Supercharger Vandalism And Theft With Dye Bombs, Cable Engravings</a></li>
</ul>
Photo courtesy: Shutterstock

Short Sellers

Politics

Tech

TSLA

Tesla CEO Elon Musk Denies Potentially Bagging $400 Million Government Contract For Armored Vehicles: 'No One Mentioned It To Me, At Least'

SMCI

Reported Earlier, Supermicro Prices $700M Private Placement Of 2.25% Convertible Senior Notes Due 2028, Amends Terms Of $1.725B 2029 Notes

ATAI

Reported Earlier, atai Life Sciences Prices Public Offering Of 26.19M Common Shares At $2.10 Each, Raising $55M

IPOs

Reported Earlier, Aardvark Therapeutics Prices $94.2M Initial Public Offering Of ~5.89M Common Shares At $16/Share, Set To Trade On NASDAQ Under 'AARD'

Euronet Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEFT#NASDAQ">EEFT</a>) reported quarterly earnings of $2.08 per share which beat the analyst consensus estimate of $2.05 by 1.46 percent. This is a 10.64 percent increase over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $1.047 billion which beat the analyst consensus estimate of $1.045 billion by 0.19 percent. This is a 9.32 percent increase over sales of $957.700 million the same period last year.

Euronet Worldwide Q4 2024 Adj. EPS $2.08 Beats $2.05 Estimate, Sales $1.047B Beat $1.045B Estimate

Ooredoo Qatar taps Nokia 5G Standalone Core to deliver advanced network services and generate new revenue streams
<ul>
<li>Nokia will deliver a modernized core network that enables Ooredoo Qatar to offer more advanced services using network slicing.</li>
<li>Network will generate new consumer and enterprise revenue streams across industries such as ports, mining and natural gas.</li>
</ul>

Ooredoo Qatar Selects Nokia 5G Standalone Core To Power Advanced Network Services And Drive New Revenue Streams

Nokia and Cellcard upgrade residential fiber broadband network in Cambodia
<ul>
<li>Cellcard deploys Nokia's next-generation XGS-PON solution, providing multi-gigabit broadband access to homes and businesses across Cambodia.</li>
<li>Cellcard uses Nokia's Lightspan and Altiplano solutions to automate and increase the performance of its residential fiber broadband network.&nbsp;&nbsp;</li>
<li>The upgraded network will enable Cellcard to provide enhanced broadband services and support new high-speed, low-latency applications such as Augmented Reality (AR) and Virtual Reality (VR).</li>
</ul>

Reported Earlier, Nokia And Cellcard Modernize Cambodia's Broadband With XGS-PON, Delivering Multi-Gigabit Speeds Nationwide

This strategic move reinforces Envirotech's commitment to expanding U.S. manufacturing, strengthening fleet services, and supporting the growing demand for commercial electric vehicles (EVs). Envirotech plans to open its new corporate headquarters and manufacturing facility in the first quarter of 2025.
The new Houston headquarters and manufacturing facility will serve as a centralized hub for corporate leadership, manufacturing, fleet sales, engineering, and service operations, positioning Envirotech for continued growth and long-term success in the commercial EV market.

EVTV

Reported Earlier, Envirotech Vehicles Relocates Headquarters To Houston, Expands U.S. Manufacturing With New 86,000-Sq.-Ft. Facility

Reported Earlier, SDG&E, A Sempra Subsidiary, Becomes First California Utility To Earn CAL/OSHA VPP Safety Certification

Barclays Delivered A RoTE Of 7.5% In Q4 2024 And 10.5% In FY24

Sony Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) reported quarterly earnings of $0.41 per share. This is a 2.5 percent increase over earnings of $0.40 per share from the same period last year. The company reported $28.970 billion in sales this quarter. This is a 14.20 percent increase over sales of $25.367 billion the same period last year.

Sony Group Corporation American Depositary Shares

SONY

Sony Group Q3 2024 GAAP EPS $0.41 Up From $0.40 YoY, Sales $28.970B Up From $25.367B YoY

Guidance

Barclays 2025 Outlook: Sees Barclays Group NII Excluding Barclays Investment Bank And Head Office Of £12.2B; Expects RoTE Of 11% In 2025

Reported Earlier, TEN Holdings Prices $10M Initial Public Offering Of 1,667,000 Common Shares At $6/Share, Shares To Trade On NASDAQ Under "XHLD"

Earnings Misses

Barclays Q4 2024 GAAP EPS $0.34 Misses $0.35 Estimate, Sales $8.927B Up From $6.950B YoY

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index in the &#8220;Fear&#8221; zone on Wednesday.
U.S. stocks settled mostly lower on Wednesday, with the Dow Jones index falling more than 200 points during the session following the release of inflation data.
The headline CPI rose 3% year over year in January, surpassing both December&#8217;s 2.9% reading and economist forecasts of 2.9%. On a monthly basis, inflation increased 0.5%, outpacing expectations of 0.3% and accelerating from December&#8217;s 0.4% gain. This marked the fastest monthly inflation rate since August 2023.
Shares of some megacap tech stocks, including Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) settled lower on Wednesday. However, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares jumped more than 2% during the session after the electric vehicle maker tumbled 6.3% on Tuesday, reaching oversold levels and extending its losing streak to five consecutive sessions.
CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) shares surged around 15% on Wednesday after the company reported better-than-expected results for its fourth quarter.
Most sectors on the S&amp;P 500 closed on a negative note, with materials, energy, and real estate stocks recording losses on Wednesday. However, consumer staples and communication services stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 225 points to 44,368.56 on Wednesday. The S&amp;P 500 fell 0.27% to 6,051.97, while the Nasdaq Composite rose 0.03% at 19,649.95 during Wednesday's session.
Investors are awaiting earnings results from Deere &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>), and Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) today.
What Is CNN Business Fear &amp; Greed Index?
At a current reading of 43.8, the index remained in the &#8220;Fear&#8221; zone on Wednesday, versus a prior reading of 44.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43656665/wall-streets-most-accurate-analysts-weigh-in-on-3-tech-telecom-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Tech &amp; Telecom Stocks With Over 3% Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

AMZN

GOOG

GOOGL

Dow Dips More Than 200 Points Following Inflation Report, Megacap Tech Stocks Edge Lower: Greed Index In 'Fear' Zone

Reported Earlier, Bell Prices $1B And $1.25B Fixed-to-Fixed Rate Notes, Offering Interest Resets Every Five Years

Zebra Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) will release its fourth-quarter financial results, before the <a href="https://www.benzinga.com/quote/zbra/earnings">opening bell, on Thursday, Feb. 13, 2025.</a>
Analysts expect the Lincolnshire, Illinois-based company to report quarterly earnings at $3.94 per share, up from $1.71 per share in the year-ago period. Zebra Technologies projects quarterly revenue of $1.32 billion, compared to $1.01 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 7, Zebra Technologies announced plans to acquire Photoneo, a leading developer and manufacturer of 3D machine vision solutions.
Zebra Technologies shares fell 0.4% to close at $352.92 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/GBX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Truist Securities analyst Jamie Cook maintained a Hold rating and raised the price target from $408 to $409 on Jan. 16, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Morgan Stanley analyst Meta Marshall maintained an Equal-Weight rating and increased the price target from $400 to $427 on Dec. 17, 2024. This analyst has an accuracy rate of 76%.</li>
<li>Barclays analyst Tim Long maintained an Equal-Weight rating and raised the price target from $347 to $407 on Oct. 31, 2024. This analyst has an accuracy rate of 74%.</li>
<li>TD Cowen analyst Joseph Giordano maintained a Buy rating and increased the price target from $380 to $425 on Oct. 30, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Baird analyst Richard Eastman maintained an Outperform rating and boosted the price target from $380 to $415 on Oct. 30, 2024. This analyst has an accuracy rate of 78%.</li>
</ul>
Considering buying ZBRA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="626" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109-1024x626.png" alt="" class="wp-image-780382" style="width:692px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109-1024x626.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109-300x183.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109-768x469.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109.png 1083w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43656665/wall-streets-most-accurate-analysts-weigh-in-on-3-tech-telecom-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Tech &amp; Telecom Stocks With Over 3% Dividend Yields</a></li>
</ul>

Price Target

Analyst Ratings

ZBRA

Zebra Technologies Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

An announcement from CalciMedica (CALC) is now available. CalciMedica, Inc. stockholders convened for the 2024 Annual Meeting, endorsing a key amen...

CalciMedica Shareholders Back Expansion and Elect Directors

CalciMedica (CALC) announced that it has commenced an underwritten public offering of its shares of common stock. All of the shares to be sold in t...

CalciMedica announces common stock offering, no amount given

CalciMedica announces proposed public offering of common stock

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on CalciMedica (CALC – Research Report) today and set a price target of $16.00. Jo...

CalciMedica's Auxora Shows Promise in Acute Pancreatitis: Analyst Recommends Buy

H.C. Wainwright analyst Joseph Pantginis lowered the firm's price target on CalciMedica (CALC) to $16 from $20 and keeps a Buy rating on the shares...

CalciMedica price target lowered to $16 from $20 at H.C. Wainwright

CalciMedica appoints Stephen Bardin as CFO

"These past few months have been very exciting for CalciMedica (CALC), punctuated by our announcement of the full data set and win ratio analysis f...

CalciMedica reports Q3 EPS (50c), consensus (50c)

Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on CalciMedica (CALC – Research Report), retaining the price target of $16.00. ...

CalciMedica's Financial Strength and Clinical Advancements Lead to Buy Rating

CalciMedica GAAP EPS of -$0.50

Lucid Capital initiated coverage of CalciMedica (CALC) with a Buy rating and $13 price target The company's lead candidate, Auxora, is a potent and...

CalciMedica initiated with a Buy at Lucid Capital

CALC

Press Releases

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

Offerings

CalciMedica Announces Proposed Public Offering of Common Stock

CalciMedica Announces Pricing of Public Offering of Common Stock

CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Comments

CalciMedica

ニュース

最新ニュース CalciMedica (NASDAQ:CALC) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル